Epidemiology of prostate cancer

被引:381
作者
Crawford, ED
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Urol, Sect Urol Oncol, Denver, CO 80262 USA
[2] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
关键词
D O I
10.1016/j.urology.2003.10.013
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Prostate cancer incidence and mortality rates vary worldwide. In the United States, prostate cancer is the most common malignancy affecting men and is the second-leading cause of cancer death. Risk of developing prostate cancer is associated with advancing age, African American ethnicity, and a positive family history, and may be influenced by diet and other factors. The incidence of prostate cancer increased sharply after the introduction of widespread screening for prostate-specific antigen (PSA), although rates have now returned to levels seen before that time. PSA screening has been associated with a shift toward diagnosis of earlier-stage disease, but this has not been accompanied by a shift toward a lower histologic grade. Although overall prostate cancer mortality rates decreased during the 1990s, it was largely because of reductions in deaths among men diagnosed with distant disease. In contrast, mortality rates for men diagnosed with localized or regional disease increased gradually during most of the 1990s before decreasing slightly among white men and reaching plateaus among African Americans. UROLOGY 62 (Suppl 6A): 3-12, 2003. (C) 2003 Elsevier Inc.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 60 条
  • [1] Does amount or type of alcohol influence the risk of prostate cancer?
    Albertsen, K
    Gronbæk, M
    [J]. PROSTATE, 2002, 52 (04) : 297 - 304
  • [2] Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer
    Albertsen, PC
    Hanley, JA
    Gleason, DF
    Barry, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 975 - 980
  • [3] [Anonymous], CANC FACTS FIG 2003
  • [4] Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy
    Bianco, FJ
    Wood, DP
    Grignon, DJ
    Sakr, WA
    Pontes, JE
    Powell, IJ
    [J]. JOURNAL OF UROLOGY, 2002, 168 (02) : 479 - 482
  • [5] Hereditary prostate cancer: Clinical aspects
    Bratt, O
    [J]. JOURNAL OF UROLOGY, 2002, 168 (03) : 906 - 913
  • [6] Screening for prostate cancer with prostate-specific antigen: beware the biases
    Bunting, PS
    [J]. CLINICA CHIMICA ACTA, 2002, 315 (1-2) : 71 - 97
  • [7] Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
    Calle, EE
    Rodriguez, C
    Walker-Thurmond, K
    Thun, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) : 1625 - 1638
  • [8] Germline mutations in the ribonuclease L gene in families showing linkage with HPC1
    Carpten, J
    Nupponen, N
    Isaacs, S
    Sood, R
    Robbins, C
    Xu, J
    Faruque, M
    Moses, T
    Ewing, C
    Gillanders, E
    Hu, P
    Buinovszky, P
    Makalowska, I
    Baffoe-Bonnie, A
    Faith, D
    Smith, J
    Stephan, D
    Wiley, K
    Brownstein, M
    Gildea, D
    Kelly, B
    Jenkins, R
    Hostetter, G
    Matikainen, M
    Schleutker, J
    Klinger, K
    Connors, T
    Xiang, Y
    Wang, Z
    De Marzo, A
    Papadopoulos, N
    Kallioniemi, OP
    Burk, R
    Meyers, D
    Grönberg, H
    Meltzer, P
    Silverman, R
    Bailey-Wilson, J
    Walsh, P
    Isaacs, W
    Trent, J
    [J]. NATURE GENETICS, 2002, 30 (02) : 181 - 184
  • [9] Prostate-specific antigen best practice policy - part I: Early detection and diagnosis of prostate cancer
    Carroll, P
    Coley, C
    McLeod, D
    Schellhammer, P
    Sweat, G
    Wasson, J
    Zietman, A
    Thompson, I
    [J]. UROLOGY, 2001, 57 (02) : 217 - 224
  • [10] MENDELIAN INHERITANCE OF FAMILIAL PROSTATE-CANCER
    CARTER, BS
    BEATY, TH
    STEINBERG, GD
    CHILDS, B
    WALSH, PC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) : 3367 - 3371